Insights from 2023 ASH Annual Meeting

 

Insights from 2023 ASH Annual Meeting
J

ASH 2023 Insights: "Smart Stop Trial - Lenalidomide, Tafasitamab, Rituximab, & Acalabrutinib Alone and With Combination Chemo for 1L DLBCL"

By Insights from 2023 ASH Annual Meeting FEATURING Jason Westin
By Insights from 2023 ASH Annual Meeting FEATURING Jason Westin
187 views
December 20, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

18:30
Pfizer Hematology

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Lymphoma
06:43

ASH 2023 Summary: "The Best of MCL - Highlights & Key Takeaways"

Insights from 2023 ASH Annual Meeting

V. Yazbeck

173 views
11:40

ASH 2023 Insights: "The European MCL Network R2 Elderly Trial - R2 v…

Insights from 2023 ASH Annual Meeting

V. Ribrag

41 views
08:29

ASH 2023 Insights: "CAR T-Cell Therapy in Aggressive Lymphomas - Ide…

Insights from 2023 ASH Annual Meeting

A. Sureda

74 views
05:12

ASH 2023 Insights: "Results From ELM-2, a Ph 2 Study of Odronextamab…

Insights from 2023 ASH Annual Meeting

J. C. Villasboas

60 views
08:30

ASH 2023 Insights: "PD-1 Blockade Before AutoSCT in R/R Classic Hodg…

Insights from 2023 ASH Annual Meeting

S. Desai

92 views
11:11

ASH 2023 Insights: "Ibrutinib and Venetoclax in Symptomatic, Treatme…

Insights from 2023 ASH Annual Meeting

J. Castillo

119 views
09:27

ASH 2023 Insights: "Ph2 EpiRCHOP Study - Tazemetostat With R-CHOP in…

Insights from 2023 ASH Annual Meeting

C. Sarkozy

106 views
09:10

ASH 2023 Insights: "Acalabrutinib Added to Lenalidomide & Rituximab …

Insights from 2023 ASH Annual Meeting

P. Strati

71 views
06:00

ASH 2023 Insights: "Effectiveness of CIT and Novel Therapies in 2L+ …

Insights from 2023 ASH Annual Meeting

L. Nastoupil

107 views
09:05

ASH 2023 Insights: "Time-Limited Exposure to a ROR1-Targeting Bispec…

Insights from 2023 ASH Annual Meeting

P. Jasani

38 views
06:09

CLL/SLL: Outcomes of Pts With Richter's Transformation Without Prior…

Insights from 2023 ASH Annual Meeting

A. Kittai

360 views
05:45

ASH 2023 Insights: "Anti-CD19 CAR T-Cell Therapy for Richter's Trans…

Insights from 2023 ASH Annual Meeting

A. Kittai

50 views
13:38

ASH 2023 Insights: "S1826 Trial - Nivo-AVD Compared to Brentuximab V…

Insights from 2023 ASH Annual Meeting

S. Castellino

35 views
02:27

ASH 2023 Insights: "Efficacy of Mosunetuzumab Monotherapy in Patient…

Insights from 2023 ASH Annual Meeting

C. Cheah

69 views
02:26

ASH 2023 Insights: "Obinutuzumab, Lenalidomide, and Venetoclax in Pa…

Insights from 2023 ASH Annual Meeting

C. Cheah

48 views
10:19

ASH 2023 Insights: "Final Analysis of the ELM-2 Study - Odronextamab…

Insights from 2023 ASH Annual Meeting

S. Ayyappan

129 views
10:57

ASH 2023 Insights: "Mosunetuzumab + Polatuzumab Vedotin in Pts With …

Insights from 2023 ASH Annual Meeting

E. Budde

132 views
13:46

ASH 2023 Insights: "Smart Stop Trial - Lenalidomide, Tafasitamab, Ri…

Insights from 2023 ASH Annual Meeting

J. Westin

187 views
30:24

ASH 2023 Insights: "Treatment of Older Patients With HL in the Moder…

Insights from 2023 ASH Annual Meeting

A. Evens

153 views
10:58

ASH 2023 Insights: "ViPOR Trial - Multi-Targeted Therapy With Veneto…

Insights from 2023 ASH Annual Meeting

C. Melani

60 views
11:05

ASH 2023 Insights: "Alliance A051301/BMT-CTN 1201 Study - Ibrutinib …

Insights from 2023 ASH Annual Meeting

C. Andreadis

41 views
06:30

ASH 2023 Insights: "Pirtobrutinib in R/R FL - Results From the Ph1/2…

Insights from 2023 ASH Annual Meeting

N. Shah

68 views
11:11

ASH 2023 Insights: "Prognostic Utility of MRD After Curative Intent …

Insights from 2023 ASH Annual Meeting

B. Sworder

135 views
08:59

ASH 2023 Insights: "SWOG S1826 Trial - Nivo-AVD vs. Bv-AVD in Older …

Insights from 2023 ASH Annual Meeting

S. Rutherford

208 views
11:43

ASH 2023 Insights: "Selection of Bispecific Antibody Therapies or CA…

Insights from 2023 ASH Annual Meeting

M. Kamdar

182 views
16:09

ASH 2023 Insights: "Addition of Inotuzumab Ozogamicin to the Conditi…

Insights from 2023 ASH Annual Meeting

I. Khouri

27 views
10:21

ASH 2023 Insights: "EOT Response Assessment After 1L Tx For Aggressi…

Insights from 2023 ASH Annual Meeting

M. Roschewski

82 views
13:06

ASH 2023 Insights: "ECOG-ACRIN E4412 Study of Ipi, Nivo, and Brentux…

Insights from 2023 ASH Annual Meeting

C. Diefenbach

24 views
18:05

ASH 2023 Insights: "Optimal Management of R/R cHL - Post-Brentuximab…

Insights from 2023 ASH Annual Meeting

N. Grover

25 views
09:56

ASH 2023 Insights: "Limited Duration Loncastuximab Tesirine With Rit…

Insights from 2023 ASH Annual Meeting

J. Pablo Alderuccio

54 views
11:42

ASH 2023 Insights: "Impact of Large Cells and Ki-67% on Outcomes in …

Insights from 2023 ASH Annual Meeting

N. Epperla

84 views
04:34

ASH 2023 Summary: "Highlights and Key Takeaways in MCL"

Insights from 2023 ASH Annual Meeting

P. Jain

196 views
05:10

ASH 2023 Insights: "Efficacy of Double Step-Up Dosing of AZD0486, a …

Insights from 2023 ASH Annual Meeting

S. Gaballa

93 views
05:41

ASH 2023 Insights: "Acalabrutinib With Rituximab as 1L Therapy for O…

Insights from 2023 ASH Annual Meeting

P. Jain

48 views
04:56

ASH 2023 Insights: "Immune Reconstitution and Infection Patterns Fol…

Insights from 2023 ASH Annual Meeting

M. Melody

115 views
10:28

ASH 2023 Insights: "Multicenter Study of MCL Outcomes Following 1L B…

Insights from 2023 ASH Annual Meeting

Y. Wang

60 views